The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Clinical Quiz: Rheumatoid Arthritis Flares
September 16th 2019Patients with rheumatoid arthritis often experience flares when symptoms and functionality worsen. Predicting flares and preventing them is a key area of research in rheumatoid arthrits (RA). In this quiz, test how familiar you are with recent findings in this area.
Nurse Practitioner Q&A: Psoriatic Arthritis 101
September 13th 2019Psoriatic arthritis can appear in a variety of ways from nail disease to peripheral joint pain. But, there are a few hallmark signs that can send a rheumatologist or rheumatology nurse in the right direction. In this Q&A, Linda Grinnell-Merrick, NP, discusses the ins and outs of a psoriatic arthritis diagnosis.
Rheumatology Nurses Society Meeting Roundup: JIA, a Missed Diagnosis and More
September 13th 2019From transitioning a pediatric rheumatology patient to adult care to re-evaluating a missed diagnosis, in this slideshow, we highlight some key presentations from the annual Rheumatology Nurses Society meeting held last month.
Riociguat for Systemic Sclerosis Digital Ulcers May Require Longer Treatment
September 12th 2019A proof of concept clinical trial for riociguat (Adempas, Bayer) for patients with systemic sclerosis indicates that longer treatment periods may be necessary to heal digital ulcers. In this trial, the treatment wasn't effective in reducing the number of digital ulcers.
IL-2 Treatment Passes Safety Trial for Systemic Lupus
September 10th 2019Low-dose interleukin-2 (IL-2) was found to be safe and well tolerated in a phase 1 and 2a trial of 12 patients with systemic lupus erythematosus (SLE). The treatment may be beneficial in reducing disease activity, researchers report in Sept. 1 issue of The Lancet Rheumatology.
Nurse Practitioner Q&A: Clues to Psoriatic Arthritis
September 9th 2019Psoriatic arthritis can manifest in a variety of ways from nail disease to peripheral joint pain. But, there are a few hallmark signs that can point a rheumatologist or rheumatology nurse in the right direction. In a presentation given at the Rheumatology Nurses Society annual meeting in August, Linda Grinnell-Merrick, NP, an allergy, immunology, and rheumatology nurse practitioner at the University of Rochester Medical Center, discussed the treatment of psoriatic arthritis.
Tips for Transitioning a Juvenile Idiopathic Arthritis Patient to Adult Care
September 9th 2019Better communication between pediatric and adult rheumatologists is especially important as pediatric patients with juvenile idiopathic arthritis transition to adult care. In this Q&A, we revisit a Rheumatology Nurses Society annual meeting presentation made last month by Cathy Patty-Resk, MSN, RN, CPNP, a pediatric rheumatology nurse practitioner with the Children’s Hospital of Michigan.
ACR’s Recommendations for Controlling Drug Costs, Improving Outcomes
September 5th 2019Affordability is a leading cause of drug abandonment among rheumatology patients. Back in April, the American College of Rheumatology issued a series of position statements designed to control drug costs while improving patient outcomes.
Incorporating the Pharmacist into the Rheumatology Practice
September 5th 2019Better treatment outcomes have been documented in studies when physicians and pharmacists work together. But it can be challenging, especially with changes in policies and procedures. In this article, Lisa Schwartz, PharmD., outlines the pros of teaming up.
Study Shows Benefits of Triple Therapy for RA
September 5th 2019Triple therapy and methotrexate‐based biologic disease‐modifying antirheumatic drug (DMARD) combinations were superior to methotrexate alone for both American College of Rheumatology (ACR50) response and remission in patients with rheumatoid arthritis, say researchers writing in Arthritis Research & Therapy last month.
Quiz: What is the best state to live in if you have rheumatoid arthritis?
September 5th 2019In this installment of our monthly rheumatoid arthritis quiz, we focus comorbidities associated with rheumatoid arthritis, adverse drug reactions and the best place to get care in the country. Learn more in this quiz.
Treatment Guidelines for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
September 5th 2019Updated treatment recommendations have been issued for ankylosing spondylitis and non-radiographic axial spondyloarthritis. There are 86 recommendations. In this slideshow, we highlight those categorized as "strongly recommended."
Potential New Lupus Treatment Passes Hurdle
August 31st 2019Anifrolumab, a potential new for lupus, just successfully completed a phase three clinical trial in which patients demonstrated reduced disease activity by significant margins, according to a statement issued by the drug’s maker AstraZeneca.